Published in J Virol on April 01, 1992
A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev (2000) 2.84
Translation of encephalomyocarditis virus RNA: parameters influencing the selection of the internal initiation site. EMBO J (1994) 2.08
Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region. J Virol (2001) 1.87
Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens. J Virol (2008) 1.65
Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus. J Virol (1992) 1.24
Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14
Attenuation of Theiler's murine encephalomyelitis virus by modifications of the oligopyrimidine/AUG tandem, a host-dependent translational cis element. J Virol (1995) 1.13
A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol (1999) 1.11
The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J Virol (1995) 1.05
Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J Virol (1993) 1.01
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons. J Virol (1998) 0.95
Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J Virol (1993) 0.94
Development of a recombinant RNA technique for the construction of chimeric RNA with a long poly(C) tract. Nucleic Acids Res (1993) 0.84
A three-nucleotide insertion in the H stem-loop of the 5' untranslated region of Theiler's virus attenuates neurovirulence. J Virol (1993) 0.83
Drosophila Dynein intermediate chain gene, Dic61B, is required for spermatogenesis. PLoS One (2011) 0.83
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res (1989) 10.50
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem Sci (1990) 4.95
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis. J Virol (1988) 3.93
Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol (1992) 3.28
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U. Virology (1990) 2.03
Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol (1991) 2.00
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5' noncoding region of genomic RNA. J Virol (1989) 1.80
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology (1991) 1.45
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
Characterization of Vilyuisk virus as a picornavirus. J Med Virol (1983) 1.35
Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J Virol (1991) 1.27
Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab Invest (1977) 1.18
Poliovirus translation initiation: differential effects of directed and selected mutations in the 5' noncoding region of viral RNAs. Virology (1991) 1.14
IMMUNOLOGICAL CHARACTERIZATION OF VILYUISK HUMAN ENCEPHALOMYELITIS VIRUS. Nature (1963) 1.13
ISOLATION AND CHARACTERIZATION OF A NEUROTROPIC AGENT (MHG VIRUS) FROM ADULT RATS. Proc Soc Exp Biol Med (1964) 0.85
Susceptibility of mice free of Theiler's virus (TO strain) to infection with TO virus. J Exp Med (1953) 0.81
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
An atomic-resolution nanomechanical mass sensor. Nat Nanotechnol (2008) 4.92
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
The effect of cold narcosis on reflex action in warm-blooded animals. J Physiol (1905) 3.73
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Popular films do not reflect current tobacco use. Am J Public Health (1994) 3.10
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (2013) 2.92
Theiler's virus-induced demyelination: prevention by immunosuppression. Science (1976) 2.59
Monoallelic expression of the interleukin-2 locus. Science (1998) 2.58
Genetic analysis using genomic representations. Proc Natl Acad Sci U S A (1998) 2.52
Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J (2000) 2.38
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology (2006) 2.24
The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21
Routine antenatal anti-D prophylaxis--is the protection adequate? Transfus Med (2011) 2.12
Denitrification, dissimilatory reduction of nitrate to ammonium, and nitrification in a bioturbated estuarine sediment as measured with N and microsensor techniques. Appl Environ Microbiol (1992) 2.12
Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology (1988) 2.11
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J Immunol (1985) 2.06
Computer-based drug-utilization review--risk, benefit, or boondoggle? N Engl J Med (1995) 1.91
Australopithecus garhi: a new species of early hominid from Ethiopia. Science (1999) 1.91
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology (1990) 1.90
Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol (1981) 1.87
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol (1982) 1.81
Evidence for two structural genes for alkaline phosphatase in Bacillus subtilis. J Bacteriol (1990) 1.79
Ultrasound-guided bilateral dual transversus abdominis plane block: a new four-point approach. Acta Anaesthesiol Scand (2011) 1.78
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol (1986) 1.76
An antigen common to a wide range of bacteria. I. The isolation of a 'common antigen' from Pseudomonas aeruginosa. Acta Pathol Microbiol Scand B (1980) 1.75
Multiple sclerosis. Animal model:Theiler's virus infection in mice. Am J Pathol (1977) 1.73
Health care needs assessment in prisons: a toolkit. J Public Health Med (2001) 1.73
Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J Immunol (1984) 1.67
A study of the Huntington's disease associated trinucleotide repeat in the Scottish population. J Med Genet (1993) 1.66
Herpes simplex virus induces a processing factor that stimulates poly(A) site usage. Cell (1989) 1.64
Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect (1995) 1.63
Gamma-hydroxybutyrate--a drug of abuse. Acta Neurol Scand (2006) 1.63
Antibiotic susceptibility and phage-type pattern of Staphylococcus aureus strains isolated from patients in general practice compared to strains from hospitalized patients. Scand J Infect Dis (1990) 1.63
Sleep disruption and mood changes associated with menopause. J Psychosom Res (1997) 1.63
Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol (2001) 1.62
Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology (1984) 1.62
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Attempted suicide, depression and physical diseases: a 1-year follow-up study. Psychother Psychosom (1994) 1.58
Neurosurgery for trigeminal neuralgia: comparison of alcohol block, neurectomy, and radiofrequency coagulation. Clin J Pain (1996) 1.58
Information in primary health care. Health Libr Rev (1995) 1.56
Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses. Infect Immun (1978) 1.55
Prophylactic Swallowing Exercises in Head and Neck Cancer Radiotherapy. Dysphagia (2015) 1.55
Combined treatment with antibacterial chemotherapeutical agents in staphylococcal infections. Q J Med (1969) 1.54
Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J Biol Chem (1995) 1.54
Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci (1976) 1.52
An investigation into the diurnal variation of the body temperature of nocturnal and other birds, and a few mammals. J Physiol (1905) 1.52
Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence. J Virol (1980) 1.52
Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun (1979) 1.50
Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci U S A (1992) 1.50
Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem (1996) 1.50
The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem (2000) 1.49
Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis (1978) 1.46
Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system. Virology (1983) 1.46
An antigen common to a wide range of bacteria. 2. A biochemical study of a "common antigen" from Pseudomonas aeruginosa. Acta Pathol Microbiol Scand B (1980) 1.45
Jaws and teeth of Australopithecus afarensis from Maka, Middle Awash, Ethiopia. Am J Phys Anthropol (2000) 1.45
Nuclear dots: actors on many stages. Immunobiology (1997) 1.45
Modulating effects of WT1 on interferon-β-vitamin D association in MS. Acta Neurol Scand (2014) 1.44
Manic-depressive illness and tyrosine hydroxylase markers. Bipolar Disorder Working Group. Lancet (1996) 1.44
Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol (2000) 1.43
Transient impairments in single muscle fibre contractile function after prolonged cycling in elite endurance athletes. Acta Physiol (Oxf) (2013) 1.42
[Visual fields defects following treatment with vigabatrin]. Ugeskr Laeger (1999) 1.41
The effect of metoprolol upon blood pressure, cerebral blood flow and oxygen consumption in patients subjected to craniotomy for cerebral tumours. Acta Anaesthesiol Scand (1994) 1.40
Follow-up of comprehensive geriatric assessment in a family medicine residency clinic. J Am Board Fam Pract (1995) 1.40
Multiple sclerosis: results of screening by the Token test in a representative sample. Ital J Neurol Sci (1992) 1.39
[Babesiosis]. Ugeskr Laeger (1998) 1.39
Ring chromosome 18 in mother and daughter. J Ment Defic Res (1970) 1.39
Reliability of histo-pathological diagnosis of squamous epithelial changes of the uterine cervix. Acta Pathol Microbiol Scand A (1978) 1.38
Retracted Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157. Infect Immun (2001) 1.37
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet (1997) 1.36
Pseudotumor cerebri syndrome without papilledema. JAMA (1972) 1.36
Characterization of Vilyuisk virus as a picornavirus. J Med Virol (1983) 1.35
Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study. Virology (1980) 1.35
A Bacillus subtilis secreted phosphodiesterase/alkaline phosphatase is the product of a Pho regulon gene, phoD. Microbiology (1996) 1.33
A multifunctional prokaryotic protein expression system: overproduction, affinity purification, and selective detection. DNA Cell Biol (1993) 1.33
Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect Immun (1977) 1.33
A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest (2001) 1.31
Managing the pharmacy benefit in Medicare HMOs: what do we really know? Health Aff (Millwood) (2000) 1.30
Parasitic disease control in a residential facility for the mentally retarded. Am J Public Health (1979) 1.30
Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology (Berl) (2001) 1.27
Nucleotide sequence identifies Vilyuisk virus as a divergent Theiler's virus. Virology (1992) 1.26
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol (1999) 1.25
Acetylene reduction (nitrogen fixation) by pulp and paper mill effluents and by Klebsiella isolated from effluents and environmental situations. Appl Microbiol (1974) 1.24
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog (1987) 1.24
Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus. J Virol (1992) 1.24
Cellular immunity in chronic Theiler's virus central nervous system infection. J Immunol (1976) 1.24
Measurements of human pressure-pain thresholds on fingers and toes. Pain (1989) 1.23
The TO strains of Theiler's viruses cause "slow virus-like" infections in mice. Ann Neurol (1979) 1.23
Temperature- and magnetic-field-dependent longitudinal spin relaxation in nitrogen-vacancy ensembles in diamond. Phys Rev Lett (2012) 1.22
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4. Rev Infect Dis (1987) 1.21
Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology (1991) 1.21
Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology (1995) 1.20